feature video

QBiotics Story - EcologicTM

U P D A T E S

Human oncology programme progresses to Clinical Phase IIA

April, 2018 Update

Our human programme for tigilanol tiglate reached an exciting milestone as we plan for the Clinical Phase IIA trial ... read more


Approaching commercialisation of our veterinary oncology pharmaceutical

April, 2018 Update

All final sections of the Canine Mast Cell Tumour (MCT) US Food and Drug Administration-Centre for Veterinary Medicine (FDA-CVM) application for tigilanol tiglate are currently ... read more


Clinical evidence for EBC-1013 wound healing pharmaceutical

April, 2018 Update

Early results from three current veterinary trials examining the ability of EBC-1013 to address burns, acute and chronic wounds are very promising... read more